3 Neil Woodford Low-P/E Shares

LONDON -- Ace City investor Neil Woodford has thrashed the FTSE 100 over the past five, 10, and 15 years. Hence, I always keep an eye on his holdings for promising investment ideas.

Woodford is very selective in picking shares for his 20 billion pound funds. Fewer than one in five of the U.K.'s top 100 companies earn a place in his market-beating portfolios.

The following three companies are all at a price-to-earnings ratio of less than 10:


Share Price (Pence)


AstraZeneca  (LSE: AZN  ) (NYSE: AZN  )






Wm. Morrison Supermarkets  (LSE: MRW  )



The pharmaceuticals industry is Woodford's biggest sector bet. And AstraZeneca is his biggest single holding, weighing in at more than 8%.

The No. 2 pharma group within the FTSE 100 is suffering falling revenues because of expiring patents on some of its blockbuster drugs. However, the market likes what it's been hearing from new chief executive Pascal Soriot, who took over last October -- particularly his detailed plans for returning Astra to growth, announced last week.

It will take some time for Soriot's strategy to bear fruit. As such, analysts are forecasting an 18% fall in earnings per share this year, followed by a 3% fall in 2014. The forecasts push the historic P/E of 7.7 up to 9.9 on the 2014 EPS number -- still firmly in value territory. There's a chunky forward dividend income of 5.6%, too.

BAE Systems
BAE Systems is another of Woodford's holdings that has seen its revenues under pressure. In BAE's case, cutbacks in defense spending in the company's major U.S. and U.K. markets have been the source of the problem.

However, while AstraZeneca's return to growth is expected to be rather protracted, news flow has been improving at BAE, and the City is forecasting a quick earnings bounce-back for the company after a 15% decline in 2012.

Analysts have penciled in EPS growth of 10% for 2013. That forecast means the historic P/E of 9.9 falls to just 9 for the current year. There's a prospective dividend income of more than 5% to boot.

Morrisons is the only supermarket Woodford holds in his funds. In reporting its annual results earlier this month, the company said it expects the challenging consumer and market environment seen in 2012 to continue in 2013.

Nevertheless, chief executive Dalton Philips was upbeat about accelerating the group's multichannel presence and chain of convenience stores. Morrisons is behind its rivals on both these fronts, but the flipside of that is it has greater scope for growth.

However, analysts are expecting group earnings to make little headway for the next year or two. After a 7% rise in EPS last year, City forecasters reckon EPS will be no higher in two years' time. As such, the historic and forward P/Es are the same -- 9.9 -- while a prospective dividend income of 4.7% is above the market average.

Woodford excels at finding big winners among unloved shares for his market-beating funds, and two of the three companies I've highlighted feature within this newly updated Motley Fool report.

You can download this report for free right now -- and enjoy reading an exclusive analysis of eight of Woodford's favorite blue chips. Simply click here.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2333468, ~/Articles/ArticleHandler.aspx, 10/21/2016 1:23:57 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,109.07 -53.28 -0.29%
S&P 500 2,137.88 -3.46 -0.16%
NASD 5,250.44 8.61 0.16%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/21/2016 12:11 PM
AZN $4952.74 Down -24.76 -0.50%
AstraZeneca CAPS Rating: No stars
AZN $30.73 Down -0.27 -0.87%
AstraZeneca CAPS Rating: ****
BA $539.36 Down -2.14 -0.40%
BAE Systems CAPS Rating: No stars
BAESY $26.35 Down -0.23 -0.85%
BAE Systems CAPS Rating: ***
MRW $229.28 Down -0.52 -0.23%
Morrisons CAPS Rating: No stars